HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: M500454-JLR200v1 47/4/778    most recent Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Wang, H. H. Articles by Wang, D. Q-H. Search for Related Content PubMed PubMed Citation Articles by Wang, H. H. Articles by Wang, D. Q-H. Social Bookmarking                      What's this?

Journal of Lipid Research, Vol. 47, 778-786, April 2006
Copyright © 2006 by American Society for Biochemistry and Molecular Biology

Overexpression of estrogen receptor increases hepatic cholesterogenesis, leading to biliary hypersecretion in mice¹

Helen H. Wang, Nezam H. Afdhal and David Q-H. Wang²

Department of Medicine, Liver Center and Gastroenterology Division, Beth Israel Deaconess Medical Center, Harvard Medical School and Harvard Digestive Diseases Center, Boston, MA

¹ This paper was presented in part at the Annual Meeting of the American Gastroenterological Association, New Orleans, LA, in 2004, and published as an abstract (Gastroenterology 2004; 126: A673).

Published, JLR Papers in Press, December 27, 2005.

² To whom correspondence should be addressed. e-mail:dqwang{at}caregroup.harvard.edu

We explored whether there is an "estrogen-ER-SREBP-2" (for estrogen-estrogen receptor subtype -sterol-regulatory element binding protein-2) pathway for regulating hepatic cholesterol biosynthesis in ovariectomized AKR mice treated with 17ß-estradial (E₂) at 6 µg/day or E₂ plus the antiestrogenic agent ICI 182,780 at 125 µg/day and on chow or fed a high-cholesterol (1%) diet for 14 days. To monitor changes in cholesterol biosynthesis and newly synthesized cholesterol secreted into bile, incorporation into digitonin-precipitable sterols in mice treated with 25 mCi of [³H]water was measured in extracts of liver and extrahepatic organs 1 h later and in hepatic biles 6 h later. ER upregulated SREBP-2, with resulting activation of SREBP-2-responsive genes in the cholesterol biosynthetic pathway. The E₂-treated mice continued to synthesize cholesterol in spite of its excess availability from high dietary cholesterol, which reflects a loss in controlling the negative feedback regulation of cholesterol synthesis. These alterations augmented biliary cholesterol secretion and enhanced the lithogenicity of bile. However, these lithogenic effects of E₂ were fully blocked by ICI 182,780. We conclude that during estrogen treatment, more newly synthesized cholesterol determined by the estrogen-ER-SREBP-2 pathway is secreted into bile, leading to biliary cholesterol hypersecretion. These studies provide insights into therapeutic approaches to cholesterol gallstones in high-risk subjects, especially those exposed to high levels of estrogen.

Supplementary key words bile • bile flow • bile salt • biliary secretion • crystallization • liquid crystals • microscopy • cholesterol saturation index

Abbreviations: ER, estrogen receptor; ER, estrogen receptor subtype ; E₂, 17ß-estradiol; OVX, ovariectomized; SREBP-2, sterol-regulatory element binding protein-2

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?